NO981133L - Ikke-reseptormedierte kontrastmidler - Google Patents

Ikke-reseptormedierte kontrastmidler

Info

Publication number
NO981133L
NO981133L NO981133A NO981133A NO981133L NO 981133 L NO981133 L NO 981133L NO 981133 A NO981133 A NO 981133A NO 981133 A NO981133 A NO 981133A NO 981133 L NO981133 L NO 981133L
Authority
NO
Norway
Prior art keywords
receptor
contrast agents
areas
cell
mediated
Prior art date
Application number
NO981133A
Other languages
English (en)
Other versions
NO981133D0 (no
Inventor
Susan H Peers
Anne Goodbody
Alfred Pollak
John Thornback
Original Assignee
Resolution Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Pharm Inc filed Critical Resolution Pharm Inc
Publication of NO981133D0 publication Critical patent/NO981133D0/no
Publication of NO981133L publication Critical patent/NO981133L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Påvisbare merkede ikke-reseptormedierte celle-assosierende forbindelser er fremskaffet til bruk i diagnostisk billeddannelse av målområder i et pattedyr. Celle-assosierende forbindelser kan bli direkte merket, eller merket via en kompleksdanner for å danne et konjugat. Slike celle-assosierende forbindelser er spesielt nyttige i å avbilde målområder slik som tumorområder og områder med infeksjon.
NO981133A 1995-09-15 1998-03-13 Ikke-reseptormedierte kontrastmidler NO981133L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/529,060 US5688489A (en) 1995-09-15 1995-09-15 Non-receptor mediated imaging agents
PCT/CA1996/000602 WO1997010266A1 (en) 1995-09-15 1996-09-09 Non-receptor mediated imaging agents

Publications (2)

Publication Number Publication Date
NO981133D0 NO981133D0 (no) 1998-03-13
NO981133L true NO981133L (no) 1998-05-13

Family

ID=24108346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981133A NO981133L (no) 1995-09-15 1998-03-13 Ikke-reseptormedierte kontrastmidler

Country Status (8)

Country Link
US (2) US5688489A (no)
EP (1) EP0853632A1 (no)
JP (1) JPH11513363A (no)
AU (1) AU6867696A (no)
CA (1) CA2231352A1 (no)
IL (1) IL123606A0 (no)
NO (1) NO981133L (no)
WO (1) WO1997010266A1 (no)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
FR2807523B1 (fr) * 2000-04-07 2002-08-30 Inst Nat Sante Rech Med UTILISATION D'UN RESTE PyA-(Z)x-pNF A DES FINS DE DETECTION, IDENTIFICATION ET/OU DOSAGE PAR FLUORESCENCE
US20030109457A1 (en) * 2001-10-25 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
GB2368339B (en) * 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
US7528227B2 (en) * 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof
JP2005525998A (ja) * 2001-08-30 2005-09-02 プラエシス ファーマシューティカルズ インコーポレーテッド 炎症性疾患の治療のための方法および組成物
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US7799757B2 (en) * 2002-06-13 2010-09-21 Michael Chorev Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
WO2005051982A1 (ja) * 2003-11-28 2005-06-09 Toagosei Co,. Ltd. 糖ペプチド及び温度応答性ミセル
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
PT2204383E (pt) * 2004-04-08 2011-10-31 Millennium Pharm Inc Processos para a preparação de eptifibatida e compostos intermediários pertinentes
US20090191105A1 (en) * 2004-08-30 2009-07-30 Kazuhiro Tanahashi Fractionation Apparatus
WO2006042661A2 (en) * 2004-10-18 2006-04-27 Cognis France S.A.S Oligopeptides and their use in cosmetics
US7563764B2 (en) * 2004-12-30 2009-07-21 E. I. Du Pont De Nemours And Company Antimicrobial peptides based on tripeptide repeats
CA2595406C (en) 2005-01-20 2017-07-11 Biomarck Pharmaceuticals, Ltd. Mucin hypersecretion inhibitors based on the structure of mans-related peptides and methods of use
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1782819A1 (en) 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
TWI303567B (en) * 2005-12-20 2008-12-01 Ind Tech Res Inst Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
WO2007098033A2 (en) 2006-02-16 2007-08-30 University Of Georgia Research Foundation, Inc . Feedback prodrug
EP1987062B1 (en) * 2006-02-23 2011-06-22 Fibrex Medical Research & Development GmbH Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
FR2900826B1 (fr) 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
RU2423376C2 (ru) * 2006-07-26 2011-07-10 Байомарк Фармасьютикалз, Лтд. Способы ослабления высвобождения медиаторов воспаления и пептиды, применяемые для этой цели
US8691761B2 (en) * 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
PL2383289T3 (pl) 2006-10-16 2015-03-31 Salk Inst Biological Studies Antagoniści somatostatyny selektywni względem receptora (SSTR2)
US8987200B2 (en) * 2006-11-16 2015-03-24 Kai Pharmaceuticals, Inc. Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders
WO2008085828A2 (en) * 2007-01-03 2008-07-17 The Johns Hopkins University Peptide modulators of angiogenesis and use thereof
EP2144615A4 (en) * 2007-04-06 2011-02-16 Kai Pharmaceuticals Inc METHOD OF USE OF GAMMA INHIBITOR COMPOUNDS FOR PAIN LIFTING
AU2009275135A1 (en) 2008-07-21 2010-01-28 Compugen Ltd. Angiopoietin derived peptides
US8865865B2 (en) * 2008-10-29 2014-10-21 Philipps-Universitat Marburg N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic
FR2940969B1 (fr) * 2009-01-09 2012-05-04 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
EP4154900B1 (en) 2009-07-29 2024-08-28 Kai Pharmaceuticals, Inc. Therapeutic agents for reducing parathyroid hormone levels
BR112012011780A2 (pt) * 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
WO2011079015A1 (en) * 2009-12-21 2011-06-30 The Regents Of The University Of California Rgd-containing cyclic peptides
FR2956115B1 (fr) * 2010-02-05 2012-04-06 Isp Investments Inc Nouveaux peptides activateurs de la caspase-14 et compositions les comprenant
EP2560675A1 (en) * 2010-04-20 2013-02-27 Novo Nordisk A/S Long-acting gastrin derivatives
EP2382963A1 (en) * 2010-04-29 2011-11-02 Cognis IP Management GmbH Cosmetic composition containing oligopeptides
EP2576594B1 (en) * 2010-05-30 2016-07-13 The Governing Council Of The University Of Toronto Mitochondrial penetrating peptides as carriers for antimicrobials
IN2013MN01582A (no) 2011-01-20 2015-06-12 Oneday Biotech And Pharma Ltd
FR2971784B1 (fr) * 2011-02-18 2015-01-02 Isp Investments Inc Nouveaux peptides activateurs de la synthese des proteines de la matrice extracellulaire et compositions cosmetiques les comprenant
WO2012123018A1 (en) * 2011-03-15 2012-09-20 Nanomed3D S.R.L. Functionalized biomaterials for tissue regeneration
LT2717896T (lt) 2011-06-08 2017-02-27 Kai Pharmaceuticals, Inc. Terapiniai agentai, skirti fosforo koncentracijos serume reguliavimui
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
EP3248609B1 (en) 2011-10-28 2019-10-16 NeoStrata Company, Inc. N-acyldipeptide derivatives and their uses
EP2820038B1 (en) * 2012-03-01 2020-06-17 Novo Nordisk A/S Glp-1 prodrugs
WO2013184204A2 (en) * 2012-03-22 2013-12-12 Duke University Linear-response nanocrystal scintillators and methods of using the same
WO2014016831A1 (en) 2012-07-23 2014-01-30 Oneday - Biotech And Pharma Ltd. Glutathione-elevating compositions and uses thereof
EP2877194A4 (en) 2012-07-25 2016-03-16 Oneday Biotech And Pharma Ltd Compositions and methods for increasing carnitine concentration in muscle tissue
NO2891663T3 (no) * 2012-08-31 2018-05-19
CN104884078B (zh) * 2012-10-17 2017-06-20 诺和诺德股份有限公司 用于口服肽递送的脂肪酸酰化d‑氨基酸
KR20140088837A (ko) * 2013-01-03 2014-07-11 한미약품 주식회사 Ｎ-말단 전하가 변형된 인슐린 분비 펩티드 유도체
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US20140296164A1 (en) * 2013-03-29 2014-10-02 Calista Therapeutics, Inc. Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
EP3143036B1 (en) * 2014-05-11 2023-08-02 Tel Hashomer Medical Research Infrastructure and Services Ltd. Par-1 based therapeutic conjugates and uses thereof
KR101470793B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 흡수촉진제로서의 펩타이드와 이를 포함하는 조성물
JPWO2016129174A1 (ja) * 2015-02-09 2017-11-16 株式会社ファーマフーズ ヒアルロン酸産生促進剤
MX377692B (es) 2015-07-16 2025-03-10 Nuritas Ltd Peptidos anti-inflamatorios y usos de los mismos.
EP3118216A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Cellular growth and proliferation promoting peptides, and uses thereof
EP3117831A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Peptides for use in promoting transport of glucose into skeletal muscle
US9856302B2 (en) * 2015-07-23 2018-01-02 General Biologicals Corporation Anti-microbial peptide and method for treating microbial infection
US10829519B2 (en) * 2015-09-18 2020-11-10 Wake Forest University Health Sciences Angiotensin (1-7) analogs and methods relating thereto
TWI619503B (zh) * 2015-12-14 2018-04-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其用途
WO2017152254A1 (en) * 2016-03-09 2017-09-14 Chu Sainte-Justine Methods for reducing perinatal morbidity and/or mortality
US10286038B2 (en) * 2016-03-11 2019-05-14 Northwestern University Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
US11759496B2 (en) * 2016-05-10 2023-09-19 Philippe Karoyan Compounds and pharmaceutical use thereof in the treatment of cancer
US10907212B2 (en) * 2016-05-14 2021-02-02 Regents Of The University Of Minnesota Inhibitors of cell adhesion
WO2017218355A1 (en) * 2016-06-15 2017-12-21 Counterpoint Biomedica Llc Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells
WO2018044812A2 (en) 2016-08-29 2018-03-08 Fred Hutchinson Cancer Research Center Chelating platform for delivery of radionuclides
AU2017318610B2 (en) * 2016-09-02 2021-12-09 The Board Of Trustees Of The University Of Illinois KIF13B-derived peptide and method of inhibiting Angiogenesis
US10898544B2 (en) * 2016-12-13 2021-01-26 Emory University Polypeptides for managing viral infections
US11116817B2 (en) * 2017-02-17 2021-09-14 The Curators Of The University Of Missouri Antimicrobial agents and compositions comprising the same
US10570177B2 (en) * 2017-03-01 2020-02-25 The Chinese University Of Hong Kong P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases
WO2018191599A1 (en) * 2017-04-14 2018-10-18 University Of Massachusetts Brown fat-selective adipokines
RU2678987C2 (ru) * 2017-04-28 2019-02-05 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Пептид для лечения болезни альцгеймера
US11981752B2 (en) * 2017-05-02 2024-05-14 Sanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
IL278311B2 (en) 2018-05-02 2024-02-01 Tel Hashomer Medical Res Infrastructure & Services Ltd Preparations and methods for the treatment of glioblastoma
KR102234027B1 (ko) * 2018-05-09 2021-03-31 서울대학교산학협력단 B형 간염 바이러스 유래 폴리펩티드 및 이의 항바이러스 용도
KR20220004618A (ko) * 2019-01-07 2022-01-11 세나 바이오사이언스 아이엔씨. 신규한 펩티드 및 이의 용도
WO2020227625A1 (en) * 2019-05-08 2020-11-12 Laura Hansen 14-3-3 targeting peptides for cancer treatment
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020257162A1 (en) 2019-06-17 2020-12-24 Biomarck Pharmaceuticals Ltd. Peptides and methods of use thereof in treating uveitis
WO2021011283A1 (en) 2019-07-12 2021-01-21 Northwestern University Insulin like growth factor binding protein bioactive peptide fragments
AU2021251208A1 (en) * 2020-04-08 2022-11-10 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
GB202008445D0 (en) * 2020-06-04 2020-07-22 Univ Court Univ Of Glasgow Insect neuropeptide analogues
US20230312643A1 (en) * 2020-09-08 2023-10-05 Sunmarine Biotech Peptide derivative with collagenase inhibitory activity, and use thereof
EP4000597A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
RU2760133C1 (ru) * 2021-04-22 2021-11-22 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства". Амиды гептапептида для лечения HMGB1-зависимых заболеваний
WO2024196750A1 (en) * 2023-03-17 2024-09-26 Trustees Of Boston University Novel polypeptide bax/npm inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
US5180816A (en) * 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US4962277A (en) * 1988-12-09 1990-10-09 Scripps Clinic And Research Foundation Deletion analogues of magainin peptides
WO1990011770A1 (en) * 1989-04-11 1990-10-18 Calgene, Inc. Use of animal-derived anti-microbial peptides for control of plant pathogens
US5585353A (en) * 1990-02-02 1996-12-17 The Rockefeller University Antibiotic peptides containing D-amino acids
US5043176A (en) * 1990-06-13 1991-08-27 Haarmann & Reimer Corp. Synergistic antimicrobial compositions
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
AU3236293A (en) * 1991-12-09 1993-07-19 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and chelating agents
US5491074A (en) * 1993-04-01 1996-02-13 Affymax Technologies Nv Association peptides
US5582995A (en) * 1993-06-11 1996-12-10 The General Hospital Corporation Methods of screening for compounds which inhibit the direct binding of Ras to Raf
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents

Also Published As

Publication number Publication date
US5837218A (en) 1998-11-17
JPH11513363A (ja) 1999-11-16
CA2231352A1 (en) 1997-03-20
EP0853632A1 (en) 1998-07-22
US5688489A (en) 1997-11-18
AU6867696A (en) 1997-04-01
NO981133D0 (no) 1998-03-13
WO1997010266A1 (en) 1997-03-20
IL123606A0 (en) 1998-10-30

Similar Documents

Publication Publication Date Title
CA2276180A1 (en) Method for activating human antigen-presenting cells, activated human antigen-presenting cells, and use thereof
RU94022254A (ru) Лиганды, содержащие гетероатом, их комплексы с металлами, способ получения, способ лечения и применение в диагностических наборах
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
TR200103525T2 (tr) Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı.
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
EP0740650A4 (en) CO-MEDICINAL PRODUCTS USED AS A REGULATED MEDICINE DELIVERY PROCESS
TR199800815A2 (en) S�lfonilaminokarbonasitler.
NZ515705A (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) alpha
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
CA2083179A1 (en) Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
AU3002699A (en) Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypesthereof, using microbial uc panca antigens
GEP20032897B (en) Epothilone Derivatives
RU94017851A (ru) Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
NO965094L (no) [aÅ-annelerte pyrrolderivater og anvendelse av disse i farmasien
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
AU7934900A (en) Method of screening for inhibitors of asp2
NO944838L (no) Arabinogalaktanderivater og anvendelser derav
RU95103436A (ru) Способ замедления прогрессирования атеросклероза коронарных артерий с помощью правастатина
FI945787A0 (fi) Sulfoniumsuoloja ja menetelmä niiden valmistamiseksi
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.